• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索1,2,3-三唑基三氯生类似物的化学空间以发现新型抗利什曼原虫化疗药物。

Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.

作者信息

Fernández de Luco Julia, Recio-Balsells Alejandro I, Ghiano Diego G, Bortolotti Ana, Belardinelli Juán Manuel, Liu Nina, Hoffmann Pascal, Lherbet Christian, Tonge Peter J, Tekwani Babu, Morbidoni Héctor R, Labadie Guillermo R

机构信息

Instituto de Química Rosario, UNR, CONICET Suipacha 531 S2002LRK Rosario Argentina

Laboratorio de Microbiología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Rosario Santa Fe 3100 S2002KTR Rosario Argentina

出版信息

RSC Med Chem. 2020 Nov 5;12(1):120-128. doi: 10.1039/d0md00291g. eCollection 2021 Jan 1.

DOI:10.1039/d0md00291g
PMID:34046604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8130612/
Abstract

Triclosan and isoniazid are known antitubercular compounds that have proven to be also active against parasites. On these grounds, a collection of 37 diverse 1,2,3-triazoles based on the antitubercular molecules triclosan and 5-octyl-2-phenoxyphenol (8PP) were designed in search of novel structures with leishmanicidal activity and prepared using different alkynes and azides. The 37 compounds were assayed against , the etiological agent of leishmaniasis, yielding some analogs with activity at micromolar concentrations and against H37Rv resulting in scarce active compounds with an MIC of 20 μM. To study the mechanism of action of these catechols, we analyzed the inhibition activity of the library on the enoyl-ACP reductase (ENR) InhA, obtaining poor inhibition of the enzyme. The cytotoxicity against Vero cells was also tested, resulting in none of the compounds being cytotoxic at concentrations of up to 20 μM. Derivative could be considered a valuable starting point for future antileishmanial drug development. The validation of a putative leishmanial InhA orthologue as a therapeutic target needs to be further investigated.

摘要

三氯生和异烟肼是已知的抗结核化合物,已证明它们对寄生虫也有活性。基于此,设计了一组基于抗结核分子三氯生和5-辛基-2-苯氧基苯酚(8PP)的37种不同的1,2,3-三唑,以寻找具有杀利什曼原虫活性的新结构,并使用不同的炔烃和叠氮化物进行制备。对这37种化合物针对利什曼病的病原体进行了检测,得到了一些在微摩尔浓度下具有活性的类似物,而针对H37Rv的检测结果显示,活性化合物稀缺,其最低抑菌浓度为20μM。为了研究这些儿茶酚的作用机制,我们分析了该文库对烯酰-ACP还原酶(ENR)InhA的抑制活性,结果显示对该酶的抑制作用较差。还测试了对Vero细胞的细胞毒性,结果表明在浓度高达20μM时,没有一种化合物具有细胞毒性。衍生物可被视为未来抗利什曼原虫药物开发的一个有价值的起点。作为治疗靶点的假定利什曼原虫InhA同源物的验证需要进一步研究。

相似文献

1
Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.探索1,2,3-三唑基三氯生类似物的化学空间以发现新型抗利什曼原虫化疗药物。
RSC Med Chem. 2020 Nov 5;12(1):120-128. doi: 10.1039/d0md00291g. eCollection 2021 Jan 1.
2
and analysis of enoyl acyl carrier protein reductase - A possible drug target.并分析烯酰基辅酶 A 还原酶——一个可能的药物靶点。
J Biomol Struct Dyn. 2021 Oct;39(16):6056-6069. doi: 10.1080/07391102.2020.1802337. Epub 2020 Aug 7.
3
Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.三氯生和异烟肼对结核分枝杆菌烯酰还原酶InhA的抑制作用。
Biochemistry. 2000 Jul 4;39(26):7645-50. doi: 10.1021/bi0008940.
4
Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌药敏和耐药菌株中强效三氯生衍生的烯酰-酰基载体蛋白还原酶InhA抑制剂的生物学评价
ChemMedChem. 2014 Nov;9(11):2528-37. doi: 10.1002/cmdc.201402255. Epub 2014 Aug 27.
5
First triclosan-based macrocyclic inhibitors of InhA enzyme.首款基于三氯生的 InhA 酶大环抑制剂。
Bioorg Chem. 2020 Jan;95:103498. doi: 10.1016/j.bioorg.2019.103498. Epub 2019 Dec 6.
6
Targeting InhA in drug-resistant Mycobacterium tuberculosis: potent antimycobacterial activity of diaryl ether dehydrozingerone derivatives.靶向耐药结核分枝杆菌中的InhA:二芳基醚脱氢姜酮衍生物的强效抗分枝杆菌活性
Arch Microbiol. 2025 Jan 15;207(2):34. doi: 10.1007/s00203-025-04238-x.
7
Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity.设计并合成 2-(2-异烟酰腙基)丙酰胺类化合物作为具有高抗结核活性的 InhA 抑制剂。
Eur J Med Chem. 2021 Nov 5;223:113668. doi: 10.1016/j.ejmech.2021.113668. Epub 2021 Jun 23.
8
Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.特征性基因表达谱可区分经异烟肼、硫乳霉素和三氯生处理的结核分枝杆菌。
Antimicrob Agents Chemother. 2003 Sep;47(9):2903-13. doi: 10.1128/AAC.47.9.2903-2913.2003.
9
Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid.2-(2-异烟酰肼叉基)丙酸的高活性抗分枝杆菌互酯的设计与合成
Pharmaceuticals (Basel). 2021 Dec 14;14(12):1302. doi: 10.3390/ph14121302.
10
Design, synthesis and in silico molecular modelling studies of 2-Hydrazineyl-2-oxoethyl-4-(1H-pyrrol-1-yb) benzoate derivatives: a potent dual DHFR and ENR-reductase inhibitors with antitubercular, antibacterial and cytotoxic potential.2-肼基-2-氧代乙基-4-(1H-吡咯-1-基)苯甲酸酯衍生物的设计、合成及计算机辅助分子模拟研究:一类具有抗结核、抗菌和细胞毒性潜力的高效双功能二氢叶酸还原酶和烯酰还原酶抑制剂
PLoS One. 2025 May 19;20(5):e0323702. doi: 10.1371/journal.pone.0323702. eCollection 2025.

引用本文的文献

1
Expanding the scope of novel 1,2,3-triazole derivatives as new antiparasitic drug candidates.扩大新型1,2,3-三唑衍生物作为新型抗寄生虫药物候选物的范围。
RSC Med Chem. 2022 Oct 31;14(1):122-134. doi: 10.1039/d2md00324d. eCollection 2023 Jan 25.
2
Synthesis, antimalarial, antileishmanial evaluation, and molecular docking study of some 3-aryl-2-styryl substituted-4(3H)-quinazolinone derivatives.某些3-芳基-2-苯乙烯基取代的-4(3H)-喹唑啉酮衍生物的合成、抗疟、抗利什曼原虫活性评价及分子对接研究
BMC Chem. 2022 Dec 2;16(1):107. doi: 10.1186/s13065-022-00903-0.
3
Triclosan: A Small Molecule with Controversial Roles.三氯生:一种具有争议性作用的小分子。
Antibiotics (Basel). 2022 May 30;11(6):735. doi: 10.3390/antibiotics11060735.

本文引用的文献

1
and analysis of enoyl acyl carrier protein reductase - A possible drug target.并分析烯酰基辅酶 A 还原酶——一个可能的药物靶点。
J Biomol Struct Dyn. 2021 Oct;39(16):6056-6069. doi: 10.1080/07391102.2020.1802337. Epub 2020 Aug 7.
2
TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration.TDR 目标 6:通过密集的化学生物基因组数据整合推动人类病原体的药物发现。
Nucleic Acids Res. 2020 Jan 8;48(D1):D992-D1005. doi: 10.1093/nar/gkz999.
3
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.含 1,2,3-三唑的杂合体作为药物化学中的先导化合物:最新概述。
Bioorg Med Chem. 2019 Aug 15;27(16):3511-3531. doi: 10.1016/j.bmc.2019.07.005. Epub 2019 Jul 4.
4
Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria.青蒿素-(异)喹啉杂合体的 C-H 活化和点击化学法:抗多药耐药性疟疾。
Angew Chem Int Ed Engl. 2019 Sep 9;58(37):13066-13079. doi: 10.1002/anie.201907224. Epub 2019 Aug 8.
5
Stacking Interactions of Heterocyclic Drug Fragments with Protein Amide Backbones.杂环药物片段与蛋白质酰胺骨架的堆积相互作用。
ChemMedChem. 2018 Apr 23;13(8):835-841. doi: 10.1002/cmdc.201700721. Epub 2018 Mar 15.
6
An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors.InhA蛋白晶体结构概述:无配体形式、与其天然配体及抑制剂形成的复合物。
Eur J Med Chem. 2018 Feb 25;146:318-343. doi: 10.1016/j.ejmech.2018.01.047. Epub 2018 Feb 4.
7
The rule of five should not impede anti-parasitic drug development.五规则不应阻碍抗寄生虫药物的研发。
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):248-249. doi: 10.1016/j.ijpddr.2017.05.003. Epub 2017 May 27.
8
Changes in Lipid and Fatty Acid Composition During Intramacrophagic Transformation of Leishmania donovani Complex Promastigotes into Amastigotes.杜氏利什曼原虫复合体前鞭毛体向无鞭毛体巨噬细胞内转化过程中脂质和脂肪酸组成的变化
Lipids. 2017 May;52(5):433-441. doi: 10.1007/s11745-017-4233-6. Epub 2017 Feb 4.
9
Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors.评估过渡态去稳定化对唑类 InhA 抑制剂停留时间变化的贡献。
J Am Chem Soc. 2017 Mar 8;139(9):3417-3429. doi: 10.1021/jacs.6b11148. Epub 2017 Feb 22.
10
Medicinal attributes of 1,2,3-triazoles: Current developments.1,2,3-三唑的药用特性:当前进展
Bioorg Chem. 2017 Apr;71:30-54. doi: 10.1016/j.bioorg.2017.01.010. Epub 2017 Jan 18.